In this study, of consecutive breast cancer cases with up to 20-years of follow-up, the annual rate of contralateral breast cancer overall was 0.6% but increased to 2%–3% per year among BRCA1/2 PV carriers. This evidence concerns the gene BRCA1 and breast carcinoma.